|
Today's Headlines
Aetna and Coventry Health Care of Florida are reclassifying certain HIV/AIDS medications labeled as specialty drugs to either generic or non-preferred brand drugs, according to Florida Insurance Commissioner Kevin M. McCarty.
» Read more
|
ADVERTISEMENT
Idiopathic Pulmonary Fibrosis (IPF)
IPF is the progressive formation of thick or scarred tissue in the lungs, resulting in loss of oxygen.
While there is currently no known cause, continued research seeks to find an answer,
alongside improved diagnosis and treatment options.
 Learn More
|
|
FDA has issued final guidance to assist industry in developing opioid drug products with potentially abuse-deterrent properties.
» Details
|
Continuing Education
Last month and this month pharmacists will be able to learn about the latest developments in diabetes treatment and management. Pharmacists can earn up to 4 hours of CPE credit with two monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics. The goal of this month’s activity is to discuss the recent updates of national U.S. guidelines for diabetes management, including hypertension and cholesterol management in patients with diabetes, in order to empower pharmacists in clinical decision-making.
Read/print the article: Click here
Take the test: Click here to log in with the Session Code 15DT16-TAJ88.
Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is
https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/
|
|
EDITOR'S PICK
Plaque psoriasis patients treated with secukinumab (Cosentyx) over ustekinumab (Stelara)—a widely used biologic—can achieve clearer skin, according to a late—breaking research session at the 73rd Annual Meeting of the American Academy of Dermatology (AAD), in San Francisco. » Details
|
|
|
Like
Tweet
